This press briefing will discuss EU actions to tackle shortages of GLP-1 receptor agonists indicated for the treatment of diabetes and in some cases for weight management in patients with obesity or weight-related conditions.

Speakers:

• Emer Cooke, Executive Director, EMA
• Karl Broich, President of the Federal Institute for Drugs and Medical Devices (BfArM)

The two speakers co-chair the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG).

The press briefing will be:

• moderated by Marie-Agnes Heine, Head of Communication, EMA;
• held in English (no translations will be provided);
• streamed live via EMA's YouTube channel

, X and LinkedIn page.